No Data
No Data
Vigil Neuroscience VIGL +15% Phase 1 Data; Exicure XCUR +28% Acquisition Deal
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Sector Update: Health Care
Vigil Neuroscience Shares Jump After Alzheimer's Disease Treatment Shows Favorable Safety Profile in Early Study
Vigil Neuroscience (VIGL) Stock Rises After Promising Alzheimer's Data - Stocks Telegraph
Mizuho Securities Maintains Vigil Neuroscience(VIGL.US) With Buy Rating
74537207 : thank you , your list helps a lot to narrow things down and do my own research, you are doing great work day after day!
nowuuuh : check out $8x8 (EGHT.US)$ too. earnings on the 4th
Jaguar8 OP nowuuuh : likely for Feb 4 ER
103851773 : Thanks Jag bro
HailTheApocalypse : thank you Mr. Jaguar
View more comments...